Epstein Barr Virus News and Research

Latest Epstein Barr Virus News and Research

Study could open new therapeutic avenues to attack herpesviruses

Human cytomegalovirus is a leading cause of birth defects and transplant failures. As it's evolved over time, this virus from the herpes family has found a way to bypass the body's defense mechanisms that usually guards against viral infections. Until now, scientists couldn't understand how it manages to do so.

28 Aug 2018

Researchers find STAT3 as therapeutic target for chronic active EBV infection

Tokyo Medical and Dental University study shows that ruxolitinib-induced inhibition of STAT3 activity blocks survival and reduces pro-inflammatory cytokine production in Epstein-Barr virus (EBV)-infected clonally proliferating T- or NK-cells in Chronic active Epstein-Barr virus infection.

20 Aug 2018

New study finds key factors behind differences in immune responses

Age, sex, and specific human genetic variants are the key factors behind differences between immune responses among healthy humans, finds a study of 1,000 individuals carried out by EPFL and the Pasteur Institute.

6 Aug 2018

Discovery of genes could lead to development of novel therapies for EBV-related cancers

VCU Massey Cancer Center researchers have identified two genes that are responsible for governing the replication of the Epstein-Barr virus, an infection that drives the growth of several types of cancer.

21 Mar 2018

UCLA researchers describe herpes virus structure associated with Kaposi's sarcoma

UCLA researchers have provided the first description of the structure of the herpes virus associated with Kaposi's sarcoma, a type of cancer.

19 Jan 2018

High fat diet linked to increased risk of relapse in kids with MS

On the other hand, high vegetable intake may halve the risk of relapse, the findings indicate. Several genetic and environmental factors, including previous infection with Epstein Barr virus, exposure to cigarette smoke, and low vitamin D levels have all been associated with a heightened risk of MS.

9 Oct 2017

Researchers create chimera virus that allows study of molecules to treat cancers

Researchers from Instituto de Medicina Molecular Lisboa have created a chimera virus that allows the study of molecules to treat cancers caused by human herpesvirus infection in mice models of disease.

18 Sep 2017

Study finds virus that causes mononucleosis could raise risk of multiple sclerosis

Like whites, Hispanic and black people who have had mononucleosis, commonly known as mono, which is caused by Epstein-Barr virus, may have an increased risk of multiple sclerosis (MS), according to a new study published in the August 30, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.

31 Aug 2017

Clinical trial shows safety, effectiveness of pre-prepared cells to treat drug-resistant viral infections

Patients who receive a hematopoietic stem cell transplant are at risk of developing potentially lethal viral infections. Some of the infections can be treated with available drugs, but they are not always effective and side effects can be significant.

8 Aug 2017

New study provides insight into impact of pediatric cancer across sub-Saharan Africa

Collated Childhood cancer statistics in sub-Saharan Africa have been published for the first time as a monograph in the peer reviewed journal ecancermedicalscience, allowing researchers and policymakers a critical new insight into the impact of pediatric cancer across this region.

28 Jul 2017

Molecular classification of gastric cancer subtypes could shape tailored treatment options

Molecular classification of the four distinct subtypes of gastric cancer could potentially shape tailored treatment options by helping to predict survival outcomes and patients' response to chemotherapy.

26 Jul 2017

Herpes virus in mountain gorillas has similarity to EBV found in humans

Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific Reports.

13 Jul 2017

Scientists develop new algorithm to decipher how immune system recognizes and binds antigens

Scientists from St. Jude Children's Research Hospital and Fred Hutchinson Cancer Research Center have developed an algorithm that functions like a Rosetta Stone to help decipher how the immune system recognizes and binds antigens.

22 Jun 2017

Researchers show how Epstein-Barr virus manages to persist inside immune system's B cells

Viruses are notorious for taking over their host's operations and using them to their own advantage. But few human viruses make themselves quite as cozy as the Epstein-Barr virus, which can be found in an estimated nine out of ten humans without causing any ill effects.

3 May 2017

Preliminary study reveals promising results of new treatment for progressive MS

A small, preliminary study may show promise of a new type of treatment for progressive multiple sclerosis (MS).

20 Apr 2017

Johns Hopkins researchers find no evidence of CMV in aggressive brain cancer tissues

In a rigorous study of tumor tissue collected from 125 patients with aggressive brain cancers, researchers at Johns Hopkins say they have found no evidence of cytomegalovirus (CMV) infection and conclude that a link between the two diseases, as claimed by earlier reports, likely does not exist.

1 Mar 2017

Research shows how protein component of Epstein-Barr virus promotes development of cancer

After an infection with the Epstein-Barr virus (EBV), the virus persists in the body throughout a person's lifetime, usually without causing any symptoms.

13 Feb 2017

Inherited CD70 deficiency increases susceptibility to Epstein-Barr virus and EBV-related cancer

Investigators at the National Institutes of Health and international colleagues have identified a genetic immune disorder characterized by increased susceptibility and poor immune control of Epstein-Barr virus (EBV) and, in some cases, an EBV-associated cancer called Hodgkin's lymphoma.

23 Dec 2016

Scientists isolate and characterize therapy-resistant dormant leukemia cells

Dr. Irmela Jeremias from Helmholtz Zentrum München and her colleagues have succeeded in finding a small population of inactive leukemia cells that is responsible for relapse of the disease.

15 Dec 2016

ACS approves $1.7 million funding for new research grants to Yale University

The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has approved funding for three new research grants totaling over $1.7 million to investigators at Yale University.

2 Dec 2016

Epstein Barr Virus News and Research

Latest Epstein Barr Virus News and Research

Study could open new therapeutic avenues to attack herpesviruses

Researchers find STAT3 as therapeutic target for chronic active EBV infection

New study finds key factors behind differences in immune responses

Discovery of genes could lead to development of novel therapies for EBV-related cancers

UCLA researchers describe herpes virus structure associated with Kaposi's sarcoma

High fat diet linked to increased risk of relapse in kids with MS

Researchers create chimera virus that allows study of molecules to treat cancers

Study finds virus that causes mononucleosis could raise risk of multiple sclerosis

Clinical trial shows safety, effectiveness of pre-prepared cells to treat drug-resistant viral infections

New study provides insight into impact of pediatric cancer across sub-Saharan Africa

Molecular classification of gastric cancer subtypes could shape tailored treatment options

Herpes virus in mountain gorillas has similarity to EBV found in humans

Scientists develop new algorithm to decipher how immune system recognizes and binds antigens

Researchers show how Epstein-Barr virus manages to persist inside immune system's B cells

Preliminary study reveals promising results of new treatment for progressive MS

Johns Hopkins researchers find no evidence of CMV in aggressive brain cancer tissues

Research shows how protein component of Epstein-Barr virus promotes development of cancer

Inherited CD70 deficiency increases susceptibility to Epstein-Barr virus and EBV-related cancer

Scientists isolate and characterize therapy-resistant dormant leukemia cells

ACS approves $1.7 million funding for new research grants to Yale University

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Epstein Barr Virus News and Research

Latest Epstein Barr Virus News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in